| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Operating expenses | ||||||||
Research and development, net of tax credits (note 6) | ||||||||
11,872 | 14,148 | 9,545 | 10,527 | 7,765 | 7,296 | 3,911 | 2,551 | 3,091 |
General and administrative | ||||||||
2,703 | 2,280 | 2,104 | 1,641 | 979 | 1,217 | 646 | 750 | 439 |
Commercial | ||||||||
2,183 | 2,464 | 2,076 | 2,166 | 2,186 | 1,593 | 1,228 | 375 | 725 |
Loss from operations | ||||||||
-16,758 | -18,892 | -13,725 | -14,334 | -10,930 | -10,106 | -5,785 | -3,676 | -4,255 |
Interest income, net of bank charges | ||||||||
415 | 603 | 821 | 672 | 500 | 447 | 85 | 89 | 90 |
Loss and comprehensive loss before income taxes | ||||||||
-16,343 | -18,289 | -12,904 | -13,662 | -10,430 | -9,659 | -5,700 | -3,587 | -4,165 |
Income tax expense | ||||||||
- | -1 | -73 | -4 | 22 | 56 | 0 | 2 | 16 |
Net loss and comprehensive loss for the period | ||||||||
-16,343 | -18,288 | -12,831 | -13,658 | -10,452 | -9,715 | -5,700 | -3,589 | -4,181 |
Weighted average number of shares outstanding, basic and diluted | ||||||||
24,548 | 24,854 | 24,490 | 13,190 | 603 | 443 | 282 | 282 | 268 |
Net loss per share, basic and diluted (note 5) | ||||||||
-0.67 | 22.38 | -0.52 | -1.04 | -17.32 | 121.07 | -20.16 | -12.71 | -15.57 |